Pharmacy board warns again of an Agostini monopoly
Christian Mouttet -
THE PHARMACY Board has once again expressed concern over a possible monopoly in the pharmaceutical industry as Agostini Ltd has announced the completion of the acquisition of Oscar Francois Ltd and its associate company Intersol Ltd. The companies were acquired under Agostini s pharmaceutical subsidiary, Smith Robertson Co Ltd.
Pharmacy Board chairman Andrew Rahaman warned of a possible rise in prices if the company becomes a monopoly. He appealed to the TT Fair Trade Commission (TTFTC) to pay special attention to the latest merger before it has to deal with the issue of dismantling it.